Rockwell Medical awards 85,000 performance stock units
Chole Timothy reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Chole Timothy reported acquisition or exercise transactions in this Form 4 filing.
ROCKWELL MEDICAL, INC. reported that SVP and Chief Commercial Officer Timothy Chole received a grant of 85,000 performance-based restricted stock units on May 20, 2025. Each unit relates to one share of common stock and was awarded at no cash cost.
The PSUs have a three-year term ending on the third anniversary of the grant date, with an expiration date of May 20, 2028. They vest on or after the first anniversary only if a stock-price performance hurdle is achieved.
The performance hurdle is met if the average closing price of Rockwell Medical’s common stock over any 60 consecutive trading days during the three-year performance period equals two times the base price. The base price for this award is $2.14, calculated from the average closing price over the ten trading days before the grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance-based restricted stock units | 85,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. These are performance-based restricted stock units ("PSU") with terms as follows. The term of each PSU award runs from the grant date through the third anniversary of the grant date. Any unvested PSUs remaining after the third anniversary will be cancelled. The performance period for the award is the same three-year period. PSUs will vest on or after the first anniversary of the grant date only if the stock price meets the performance hurdle. The performance hurdle is met if the average closing price of the Company's common stock over any 60 consecutive trading days during the performance period equals two times the base price. The base price was calculated as the average closing price over the ten trading days ending on the trading day prior to the grant date and is $2.14 for this award.
Key Figures
Key Terms
Performance-based restricted stock units financial
performance hurdle financial
base price financial
average closing price financial
trading days financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Rockwell Medical (RMTI) disclose for Timothy Chole?
How many performance stock units did RMTI grant to its Chief Commercial Officer?
What is the vesting schedule for the Rockwell Medical (RMTI) performance-based RSUs?
What stock-price hurdle must be met for RMTI’s performance RSUs to vest?
How was the base price determined for Rockwell Medical’s PSU grant to Timothy Chole?
When do the newly granted Rockwell Medical (RMTI) PSUs expire if unvested?
AI-generated analysis. How Rhea-AI works. Not financial advice.